About TechsoMed
TechsoMed is a global medical imaging software company specializing in AI-powered image-guided ablation therapy (IGAT) systems for cancer treatment. Founded in 2015 and headquartered in Or-yehuda, Israel, the company addresses critical challenges in minimally invasive oncology procedures where more than half of treatments fail to completely eliminate cancerous tissue. The company's flagship BioTraceIO360 platform represents the world's first FDA-cleared software for tissue response prediction in tumor ablation. The platform compresses thousands of imaging frames into one actionable interface, providing physicians with 360-degree intelligent visualization throughout the entire ablation workflow—from pre-procedure planning through real-time monitoring to post-treatment verification. BioTrace delivers risk-aware 3D modeling, smarter needle path planning, real-time margin visualization, in-procedure tumor coverage assessment, and predictive tissue response analysis. The system is vendor-agnostic and integrates with standard medical imaging modalities including ultrasound, CT, and MRI. TechsoMed has received multiple FDA clearances, including De Novo clearance for tissue response prediction and 510(k) clearances for liver and kidney ablation applications. The company operates subsidiaries in Germany (in partnership with Fraunhofer Mevis) and Japan, and has established strategic partnerships with major healthcare technology companies including Medtronic, GE HealthCare, and Lenovo. TechsoMed's mission extends beyond current applications, with a roadmap targeting expansion into embolization therapy, radiation therapy, cryoablation, pain management, and cardiovascular ablation to make intelligent minimally invasive solutions accessible to patients everywhere.
Mission & Story
Mission
Tackle challenges in under-utilized verticals in minimally invasive therapies through AI-powered smart software tools with the goal of making them accessible for everyone, everywhere
Clinical Focus
Medical conditions and clinical areas addressed by TechsoMed.
Who It Serves
Milestones & Awards
Recent Milestones
FDA 510(k) clearance for kidney ablation (September 2025), strategic collaboration with Medtronic announced (October 2025), partnership with Hadassah Medical Center for AI-driven radiotherapy (July 2025), U.S. launch of BioTraceIO Vision and BioTraceIO Precision (July 2024)
Awards & Recognition
World's First FDA-Cleared Software for tissue response prediction
Key Partnerships
Social & Media
Follow on
Latest Updates
Test
Hadassah and TechsoMed Partner to Enhance Cancer Treatment with Advanced AI-Driven Image-Guided Therapy Solutions Powered by Big Data
Techsomed and Medtronic to Collaborate on Image Guided Ablation Therapy
Techsomed Receives FDA 510(k) Clearance Expanding BioTraceIO360 Platform to Kidney Ablation Advancing a Unified Multi-Organ Image-Guided Therapy Platform
Company Details
- Founded
- 2015
- Headquarters
- Or-yehuda, Israel
- Employees
- 11-50
Work here?
Claim this listing to update company information and connect with our audience.
Claim This ListingMarket
Surgical AI & RoboticsSecurity & Compliance
Official Sources
Similar Companies in this Market
View all 58 →
3D-Side
AI-powered 3D preoperative planning and patient-specific medical devices for surgical workflow optimization and planning.
Activ Surgical
series b · 40 employees
Activ Surgical provides intraoperative surgical intelligence enabling surgeons to view critical physiological structures and functions in real-time.
AIbolit Technologies
Aibolit Technologies (Aibo Health) provides an AI- and AR-powered perioperative digital platform that optimizes operating room workflows, enhances surgical quality, and improves training for nurses, surgeons, and OR managers across hospitals and ambulatory surgery centers.
Asensus Surgical
Asensus Surgical develops robotic-assisted surgical systems integrated with Augmented Intelligence to provide real-time insights during minimally invasive procedures. The company's Senhance® Surgical System and Intelligent Surgical Unit™ deliver data-driven decision support to surgeons, enhancing precision, efficiency, and patient outcomes.
Augmedics
Augmedics develops augmented reality surgical navigation technology for spine surgery. Their xvision Spine System provides surgeons with x-ray vision through AR headsets, enabling them to visualize patient anatomy in 3D during procedures without looking away at screens.
Augmedit
11-50 employees
Augmedit develops augmented reality medical software that guides surgeons through complex procedures using 3D holograms generated from medical imaging. The company's platform converts 2D DICOM images into interactive 3D models for surgical planning, patient education, and intra-operative visualization.
Brainlab
Brainlab develops hardware and software technology for surgery and radiation therapy to help healthcare providers, physicians and their patients fight cancer and other conditions of the brain and body.
Caranx Medical
Caranx Medical develops surgical AI and robotics solutions for healthcare providers. The company focuses on advancing surgical precision and outcomes through innovative technology platforms.
Data Accuracy Notice: Company information on HealthAI Central is compiled from public sources and updated regularly. While we strive for accuracy, details such as funding figures, employee counts, and product offerings may change. We recommend verifying critical information directly with the company before making business decisions.